Denali Therapeutics Inc. · NASDAQ:DNLI

BlackRock, Inc. reported a 7.20% stake in Denali Therapeutics Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 17, 2025

BlackRock, Inc. reported a 7.20% stake in Denali Therapeutics Inc., 10,490,610 shares, as a passive investor on Mar 31, 2025. Filed Apr 17, 2025 (Schedule 13G/A).

Stake
7.20%
Shares
10,490,610
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.7.20%10,490,610

Source

View original at SEC

Related